Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Taysha Gene Therapies, Inc.

Clinical trials sponsored by Taysha Gene Therapies, Inc., explained in plain language.

Taysha Gene Therapies, Inc. TSHA NASDAQ

Gene therapy company focused on rare monogenic diseases of the central nervous system.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2

Gene therapy hope for toddlers with rett syndrome

Disease control Recruiting now

This study tests a one-time gene therapy called TSHA-102 in girls aged 2 to 4 with Rett syndrome, a severe genetic disorder. The therapy is given as a single injection into the spine. The main goal is to check if it is safe and tolerable, and to see early signs of whether it help…

Phase: PHASE3 • Sponsor: Taysha Gene Therapies, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC